IL123888A0 - Anti-fas antibodies - Google Patents

Anti-fas antibodies

Info

Publication number
IL123888A0
IL123888A0 IL12388898A IL12388898A IL123888A0 IL 123888 A0 IL123888 A0 IL 123888A0 IL 12388898 A IL12388898 A IL 12388898A IL 12388898 A IL12388898 A IL 12388898A IL 123888 A0 IL123888 A0 IL 123888A0
Authority
IL
Israel
Prior art keywords
fas antibodies
fas
antibodies
Prior art date
Application number
IL12388898A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL123888A0 publication Critical patent/IL123888A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL12388898A 1997-04-01 1998-03-30 Anti-fas antibodies IL123888A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8295397 1997-04-01
JP16908897 1997-06-25
JP27606497 1997-10-08

Publications (1)

Publication Number Publication Date
IL123888A0 true IL123888A0 (en) 1998-10-30

Family

ID=27304060

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12388898A IL123888A0 (en) 1997-04-01 1998-03-30 Anti-fas antibodies

Country Status (17)

Country Link
EP (1) EP0909816A1 (es)
KR (1) KR19980080993A (es)
CN (1) CN1207395A (es)
AR (1) AR010139A1 (es)
AU (1) AU734758B2 (es)
BR (1) BR9803296A (es)
CA (1) CA2233783A1 (es)
CZ (1) CZ294340B6 (es)
HU (1) HUP9800744A3 (es)
ID (1) ID20117A (es)
IL (1) IL123888A0 (es)
NO (1) NO981454L (es)
NZ (1) NZ330095A (es)
PL (1) PL325667A1 (es)
RU (1) RU2212412C2 (es)
TR (1) TR199800604A2 (es)
TW (1) TW526205B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
EP1818343B1 (en) * 1998-01-23 2012-04-11 F. Hoffmann-La Roche AG Antibodies against human IL-12
WO1999065935A2 (en) * 1998-06-18 1999-12-23 Karolinska Innovations Ab Fas peptides and antibodies for modulating apoptosis
AU757961B2 (en) * 1998-09-30 2003-03-13 Sankyo Company Limited Anti-Fas antibodies
EP1180369A4 (en) 1999-05-24 2002-07-24 Sankyo Co ANTI-FAS ANTIBODY MEDICAL COMPOSITIONS
TWI318983B (en) 2000-05-02 2010-01-01 Uab Research Foundation An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
WO2003022299A1 (en) * 2001-08-01 2003-03-20 Genset S.A. Genobix agonists and antagonists for use in the treatment of metabolic disorders
EP2383290B1 (en) 2001-08-23 2019-05-08 Rsr Limited Epitope regions of a thyrotropin (tsh) receptor, uses thereof and antibodies thereto
ES2357225T3 (es) 2001-11-01 2011-04-20 Uab Research Foundation Combinaciones de anticuerpos anti-dr5 y anticuerpos anti-dr4 y otros agentes terapéuticos.
KR101307868B1 (ko) 2004-01-07 2013-09-12 조마 테크놀로지 리미티드 Ｍ-ｃｓｆ-특이적 단일클론 항체 및 그것의 사용
WO2010013498A1 (ja) * 2008-08-01 2010-02-04 学校法人聖マリアンナ医科大学 変形性関節症治療剤又は予防剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09503672A (ja) * 1993-10-14 1997-04-15 イミュネックス・コーポレーション Ｆａｓ拮抗剤とその利用
NZ279108A (en) * 1994-01-07 1997-06-24 Immunex Corp Human fas (tgf/ngf receptor) ligand proteins coding sequences and production
AU6091496A (en) * 1995-06-07 1996-12-30 Chiron Corporation Antibodies to fas antigen capable of inhibiting apoptosis
GB9523469D0 (en) * 1995-11-16 1996-01-17 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
EP0909816A1 (en) 1999-04-21
NO981454L (no) 1998-10-02
AU5970198A (en) 1998-10-08
HUP9800744A3 (en) 2001-04-28
KR19980080993A (ko) 1998-11-25
CZ98598A3 (cs) 1998-10-14
BR9803296A (pt) 2000-01-11
TW526205B (en) 2003-04-01
RU2212412C2 (ru) 2003-09-20
AR010139A1 (es) 2000-05-17
TR199800604A3 (tr) 1999-10-21
HUP9800744A2 (hu) 1999-02-01
HU9800744D0 (en) 1998-05-28
TR199800604A2 (xx) 1999-10-21
ID20117A (id) 1998-10-01
NO981454D0 (no) 1998-03-31
CZ294340B6 (cs) 2004-12-15
PL325667A1 (en) 1998-10-12
CA2233783A1 (en) 1998-10-01
CN1207395A (zh) 1999-02-10
NZ330095A (en) 1998-12-23
AU734758B2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
GB9809839D0 (en) Antibody
GB9603256D0 (en) Antibodies
GB2325840B (en) Heater-sensor complex
IL128406A0 (en) Monoclonal antibodies
HK1029035A1 (en) Teeth-cleansing means
HUP9903299A3 (en) Anti-fas antibodies
GB9705787D0 (en) Modified dendroaspins
GB9703681D0 (en) Protein complemention
GB9719879D0 (en) Protein
IL123888A0 (en) Anti-fas antibodies
EP1018551A4 (en) MEGSINE PROTEIN
GB9715522D0 (en) Assays
AU136215S (en) Copier
GB9818915D0 (en) Antibodies
GB9828700D0 (en) Antibody
HUP9901579A3 (en) Antibodies specific for alpha-d-integrin
GB9720784D0 (en) Protein
GB9718911D0 (en) Monoclonal antibodies
GB9825184D0 (en) Antigen
GB9819411D0 (en) Antibodies
ZA982719B (en) Anti-fas antibodies
GB9708589D0 (en) Seurity means
GB9726147D0 (en) Antigens
GB2314014B (en) Closure-arrangements for loose-covers
GB9816327D0 (en) Antibody